Single-cell RNA sequencing identifies an inflammatory subpopulation of mesenchymal stromal cells in patients with multiple myeloma.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
Nature Cancer Open Access 20 April 2023
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Dhodapkar, M. V. Blood 128, 2599–2606 (2016).
Das, R. et al. Nat. Med. 22, 1351–1357 (2016).
Zavidij, O. et al. Nat. Cancer 1, 493–506 (2020).
Reagan, M. R. & Ghobrial, I. M. Clin. Cancer Res. 18, 342–349 (2011).
de Jong, M. E. M. et al. Nat. Immunol. https://doi.org/10.1038/s41590-021-00931-3 (2021).
Baryawno, N. et al. Cell 177, 1915–1932.e16 (2019).
Lemaitre, L. et al. Int. J. Mol. Sci. 21, 3854 (2020).
Vande Broek, I. et al. Br. J. Cancer 88, 855–862 (2003).
Qian, H., Le Blanc, K. & Sigvardsson, M. J. Biol. Chem. 287, 25795–25807 (2012).
Munshi, N. C. et al. Blood Adv. 4, 5988–5999 (2020).
Alameda, D. et al. Haematologica 105, e470–e473 (2020).
R.S.P. has no competing interests to disclose. N.J.H. is a consultant for Constellation Pharmaceuticals. I.M.G has a consulting and advisory role with Celgene, Takeda, Bristol-Myers Squibb, Genentech, Janssen Pharmaceuticals and Amgen and has received research funding/honoraria from Celgene, Takeda, Bristol-Myers Squibb, Janssen Pharmaceuticals and Amgen. G.G. receives research funds from IBM and Pharmacyclics and is an inventor on patent applications related to MuTect, ABSOLUTE, MutSig, MSMuTect, MSMutSig, MSIdetect, POLYSOLVER and TensorQTL. G.G. is a founder, consultant and holds privately held equity in Scorpion Therapeutics.
About this article
Cite this article
Sklavenitis-Pistofidis, R., Haradhvala, N.J., Getz, G. et al. Inflammatory stromal cells in the myeloma microenvironment. Nat Immunol 22, 677–678 (2021). https://doi.org/10.1038/s41590-021-00947-9